Chair
Member
Audit Committee Position

Kenneth E. Ludlum

Mr. Ludlum currently serves as a board member and an advisor to private medical and biotechnology companies. Mr. Ludlum served as Chief Financial Officer of CareDx, Inc., a medical diagnostic company, from March 2014 to April 2016. From April 2011 to October 2013, Mr. Ludlum served as Vice President and Chief Financial Officer, and Head of Operations for Endogastric Solutions, Inc., a medical device company. More than five years ago, Mr. Ludlum also serves as CFO for two other publicly –held companies, Perclose, Inc. from 1995 to 2000, and Alteon, Inc. from 1992 to 1994. He has also served on the board of directors and as Chair of the Audit Committee of several public and private medical or biotechnology companies. Mr. Ludlum holds a B.S. in Business Administration from Lehigh University and a M.B.A. from Columbia University Graduate School of Business. Mr. Ludlum brings to the Board over 30 years of business and financial experience working with healthcare and biotechnology companies. His service as chief financial officer at several public companies has provided him with extensive financial and accounting experience, and knowledge of accounting principles, financial reporting rules, and regulations. With his background in investment banking, he also brings a unique perspective to the Board.

Chair

Robert A. Gunst

Mr. Gunst joined the Board in June 2004 and was appointed Chairman of the Board in September 2004. Mr. Gunst has been a private investor since 1999. Mr. Gunst served as president and chief executive officer of The Good Guys, Inc., an electronics retailer, from 1990 to 1999, and as a member of its board of directors from 1986 to 1999.  Prior to joining The Good Guys, Mr. Gunst held senior management and director positions at Shaklee Corporation, La Petite Boulangerie, Inc. and PepsiCo Foods International, both subsidiaries of PepsiCo, Inc., Victoria Station Incorporated, and The First National Bank of Chicago.  He holds a Bachelor of Arts degree in Economics from Dartmouth College and a Masters Degree in Business Administration from the University of Chicago’s Graduate School of Business. Mr. Gunst brings to the Board knowledge and experience gained from decades of managing and directing public and private companies across several industries.

Member

Joshua H. Levine

Mr. Levine joined the Board in June 2018 and is currently President and Chief Executive Officer at Accuray Incorporated, a manufacturer of radiation oncology systems. Mr. Levine brings extensive experience from a career spanning three decades in the medical device/medical technology industry. Mr. Levine served as President and Chief Executive Officer of Mentor Corporation from 2004 to 2009 and led the company through a strategic transformation prior to its sale to Johnson & Johnson. Mr. Levine spent a total of 15 years at Mentor, where he held various Sales, Marketing and Management roles including Chief Operating Officer and Senior Vice President of Global Sales and Marketing. Prior to Mentor, Mr. Levine served as President and Chief Executive Officer of Immucor Corporation. Mr. Levine holds a Bachelor of Arts degree in Communications from the University of Arizona and has completed Executive Management Programs at Stanford University, Graduate School of Business and the University of Pennsylvania, Wharton School.

Member

Audit Committee Charter

Download
Compensation Committee Position

Kenneth E. Ludlum

Mr. Ludlum currently serves as a board member and an advisor to private medical and biotechnology companies. Mr. Ludlum served as Chief Financial Officer of CareDx, Inc., a medical diagnostic company, from March 2014 to April 2016. From April 2011 to October 2013, Mr. Ludlum served as Vice President and Chief Financial Officer, and Head of Operations for Endogastric Solutions, Inc., a medical device company. More than five years ago, Mr. Ludlum also serves as CFO for two other publicly –held companies, Perclose, Inc. from 1995 to 2000, and Alteon, Inc. from 1992 to 1994. He has also served on the board of directors and as Chair of the Audit Committee of several public and private medical or biotechnology companies. Mr. Ludlum holds a B.S. in Business Administration from Lehigh University and a M.B.A. from Columbia University Graduate School of Business. Mr. Ludlum brings to the Board over 30 years of business and financial experience working with healthcare and biotechnology companies. His service as chief financial officer at several public companies has provided him with extensive financial and accounting experience, and knowledge of accounting principles, financial reporting rules, and regulations. With his background in investment banking, he also brings a unique perspective to the Board.

Chair

Robert A. Gunst

Mr. Gunst joined the Board in June 2004 and was appointed Chairman of the Board in September 2004. Mr. Gunst has been a private investor since 1999. Mr. Gunst served as president and chief executive officer of The Good Guys, Inc., an electronics retailer, from 1990 to 1999, and as a member of its board of directors from 1986 to 1999.  Prior to joining The Good Guys, Mr. Gunst held senior management and director positions at Shaklee Corporation, La Petite Boulangerie, Inc. and PepsiCo Foods International, both subsidiaries of PepsiCo, Inc., Victoria Station Incorporated, and The First National Bank of Chicago.  He holds a Bachelor of Arts degree in Economics from Dartmouth College and a Masters Degree in Business Administration from the University of Chicago’s Graduate School of Business. Mr. Gunst brings to the Board knowledge and experience gained from decades of managing and directing public and private companies across several industries.

Member

Joshua H. Levine

Mr. Levine joined the Board in June 2018 and is currently President and Chief Executive Officer at Accuray Incorporated, a manufacturer of radiation oncology systems. Mr. Levine brings extensive experience from a career spanning three decades in the medical device/medical technology industry. Mr. Levine served as President and Chief Executive Officer of Mentor Corporation from 2004 to 2009 and led the company through a strategic transformation prior to its sale to Johnson & Johnson. Mr. Levine spent a total of 15 years at Mentor, where he held various Sales, Marketing and Management roles including Chief Operating Officer and Senior Vice President of Global Sales and Marketing. Prior to Mentor, Mr. Levine served as President and Chief Executive Officer of Immucor Corporation. Mr. Levine holds a Bachelor of Arts degree in Communications from the University of Arizona and has completed Executive Management Programs at Stanford University, Graduate School of Business and the University of Pennsylvania, Wharton School.

Member

Compensation Committee Charter

Download
Compliance Committee Position

Barbara R. Paul, M.D.

Dr. Paul serves as an advisor and board member to healthcare companies. In addition to her role on the board of Natus Medical, she serves on the board of Quorum Health Corporation, an owner and operator of general acute care hospitals and outpatient service providers. She served as Senior Vice President & Chief Medical Officer at Community Health Systems (CHS) from July 2007 to January 2015. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. (now Golden Living, Inc.).  Dr. Paul's career is grounded by twelve years as a board-certified internist and full-time primary care physician. She also worked at the federal Medicare program (Centers for Medicare & Medicaid Services, CMS) for appointees of Presidents Clinton and Bush. She was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin - Madison and earned her medical degree from Stanford University School of Medicine.

Chair

Lisa Wipperman Heine

Ms. Heine joined the Board in June 2018 and is currently Chief Operating Officer at Mitralign, Inc., a venture backed innovator of transcatheter heart valve technologies. Prior to joining Mitralign, she was the Founder and Principal at deArca Strategic Solutions, LLC, a consulting firm focused on helping medtech companies assess, develop and execute strategies related to market opportunities and technology adoption. Lisa has also served in multiple leadership roles at Covidien, Inc., including Global Vice President of Medical Affairs for Vascular Therapies. During her tenure at Covidien, she helped drive the strategy in support of a $1.7B business and was also responsible for leading the strategy and operations of Clinical Affairs, Healthcare Economics, Policy and Reimbursement and Medical Education functions. Lisa also currently serves as a member of the Board of Directors of Surmodics Inc. She received her undergraduate degree from St. Olaf College and graduate degree from the University of Manitoba.

Member
Nominating and Corporate Governance Committee Position

Barbara R. Paul, M.D.

Dr. Paul serves as an advisor and board member to healthcare companies. In addition to her role on the board of Natus Medical, she serves on the board of Quorum Health Corporation, an owner and operator of general acute care hospitals and outpatient service providers. She served as Senior Vice President & Chief Medical Officer at Community Health Systems (CHS) from July 2007 to January 2015. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. (now Golden Living, Inc.).  Dr. Paul's career is grounded by twelve years as a board-certified internist and full-time primary care physician. She also worked at the federal Medicare program (Centers for Medicare & Medicaid Services, CMS) for appointees of Presidents Clinton and Bush. She was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin - Madison and earned her medical degree from Stanford University School of Medicine.

Chair

Robert A. Gunst

Mr. Gunst joined the Board in June 2004 and was appointed Chairman of the Board in September 2004. Mr. Gunst has been a private investor since 1999. Mr. Gunst served as president and chief executive officer of The Good Guys, Inc., an electronics retailer, from 1990 to 1999, and as a member of its board of directors from 1986 to 1999.  Prior to joining The Good Guys, Mr. Gunst held senior management and director positions at Shaklee Corporation, La Petite Boulangerie, Inc. and PepsiCo Foods International, both subsidiaries of PepsiCo, Inc., Victoria Station Incorporated, and The First National Bank of Chicago.  He holds a Bachelor of Arts degree in Economics from Dartmouth College and a Masters Degree in Business Administration from the University of Chicago’s Graduate School of Business. Mr. Gunst brings to the Board knowledge and experience gained from decades of managing and directing public and private companies across several industries.

Member

Lisa Wipperman Heine

Ms. Heine joined the Board in June 2018 and is currently Chief Operating Officer at Mitralign, Inc., a venture backed innovator of transcatheter heart valve technologies. Prior to joining Mitralign, she was the Founder and Principal at deArca Strategic Solutions, LLC, a consulting firm focused on helping medtech companies assess, develop and execute strategies related to market opportunities and technology adoption. Lisa has also served in multiple leadership roles at Covidien, Inc., including Global Vice President of Medical Affairs for Vascular Therapies. During her tenure at Covidien, she helped drive the strategy in support of a $1.7B business and was also responsible for leading the strategy and operations of Clinical Affairs, Healthcare Economics, Policy and Reimbursement and Medical Education functions. Lisa also currently serves as a member of the Board of Directors of Surmodics Inc. She received her undergraduate degree from St. Olaf College and graduate degree from the University of Manitoba.

Member

Nominating and Corporate Governance Committee Charter

Download

Kenneth E. Ludlum

Mr. Ludlum currently serves as a board member and an advisor to private medical and biotechnology companies. Mr. Ludlum served as Chief Financial Officer of CareDx, Inc., a medical diagnostic company, from March 2014 to April 2016. From April 2011 to October 2013, Mr. Ludlum served as Vice President and Chief Financial Officer, and Head of Operations for Endogastric Solutions, Inc., a medical device company. More than five years ago, Mr. Ludlum also serves as CFO for two other publicly –held companies, Perclose, Inc. from 1995 to 2000, and Alteon, Inc. from 1992 to 1994. He has also served on the board of directors and as Chair of the Audit Committee of several public and private medical or biotechnology companies. Mr. Ludlum holds a B.S. in Business Administration from Lehigh University and a M.B.A. from Columbia University Graduate School of Business. Mr. Ludlum brings to the Board over 30 years of business and financial experience working with healthcare and biotechnology companies. His service as chief financial officer at several public companies has provided him with extensive financial and accounting experience, and knowledge of accounting principles, financial reporting rules, and regulations. With his background in investment banking, he also brings a unique perspective to the Board.

Robert A. Gunst

Mr. Gunst joined the Board in June 2004 and was appointed Chairman of the Board in September 2004. Mr. Gunst has been a private investor since 1999. Mr. Gunst served as president and chief executive officer of The Good Guys, Inc., an electronics retailer, from 1990 to 1999, and as a member of its board of directors from 1986 to 1999.  Prior to joining The Good Guys, Mr. Gunst held senior management and director positions at Shaklee Corporation, La Petite Boulangerie, Inc. and PepsiCo Foods International, both subsidiaries of PepsiCo, Inc., Victoria Station Incorporated, and The First National Bank of Chicago.  He holds a Bachelor of Arts degree in Economics from Dartmouth College and a Masters Degree in Business Administration from the University of Chicago’s Graduate School of Business. Mr. Gunst brings to the Board knowledge and experience gained from decades of managing and directing public and private companies across several industries.

Joshua H. Levine

Mr. Levine joined the Board in June 2018 and is currently President and Chief Executive Officer at Accuray Incorporated, a manufacturer of radiation oncology systems. Mr. Levine brings extensive experience from a career spanning three decades in the medical device/medical technology industry. Mr. Levine served as President and Chief Executive Officer of Mentor Corporation from 2004 to 2009 and led the company through a strategic transformation prior to its sale to Johnson & Johnson. Mr. Levine spent a total of 15 years at Mentor, where he held various Sales, Marketing and Management roles including Chief Operating Officer and Senior Vice President of Global Sales and Marketing. Prior to Mentor, Mr. Levine served as President and Chief Executive Officer of Immucor Corporation. Mr. Levine holds a Bachelor of Arts degree in Communications from the University of Arizona and has completed Executive Management Programs at Stanford University, Graduate School of Business and the University of Pennsylvania, Wharton School.

Kenneth E. Ludlum

Mr. Ludlum currently serves as a board member and an advisor to private medical and biotechnology companies. Mr. Ludlum served as Chief Financial Officer of CareDx, Inc., a medical diagnostic company, from March 2014 to April 2016. From April 2011 to October 2013, Mr. Ludlum served as Vice President and Chief Financial Officer, and Head of Operations for Endogastric Solutions, Inc., a medical device company. More than five years ago, Mr. Ludlum also serves as CFO for two other publicly –held companies, Perclose, Inc. from 1995 to 2000, and Alteon, Inc. from 1992 to 1994. He has also served on the board of directors and as Chair of the Audit Committee of several public and private medical or biotechnology companies. Mr. Ludlum holds a B.S. in Business Administration from Lehigh University and a M.B.A. from Columbia University Graduate School of Business. Mr. Ludlum brings to the Board over 30 years of business and financial experience working with healthcare and biotechnology companies. His service as chief financial officer at several public companies has provided him with extensive financial and accounting experience, and knowledge of accounting principles, financial reporting rules, and regulations. With his background in investment banking, he also brings a unique perspective to the Board.

Robert A. Gunst

Mr. Gunst joined the Board in June 2004 and was appointed Chairman of the Board in September 2004. Mr. Gunst has been a private investor since 1999. Mr. Gunst served as president and chief executive officer of The Good Guys, Inc., an electronics retailer, from 1990 to 1999, and as a member of its board of directors from 1986 to 1999.  Prior to joining The Good Guys, Mr. Gunst held senior management and director positions at Shaklee Corporation, La Petite Boulangerie, Inc. and PepsiCo Foods International, both subsidiaries of PepsiCo, Inc., Victoria Station Incorporated, and The First National Bank of Chicago.  He holds a Bachelor of Arts degree in Economics from Dartmouth College and a Masters Degree in Business Administration from the University of Chicago’s Graduate School of Business. Mr. Gunst brings to the Board knowledge and experience gained from decades of managing and directing public and private companies across several industries.

Joshua H. Levine

Mr. Levine joined the Board in June 2018 and is currently President and Chief Executive Officer at Accuray Incorporated, a manufacturer of radiation oncology systems. Mr. Levine brings extensive experience from a career spanning three decades in the medical device/medical technology industry. Mr. Levine served as President and Chief Executive Officer of Mentor Corporation from 2004 to 2009 and led the company through a strategic transformation prior to its sale to Johnson & Johnson. Mr. Levine spent a total of 15 years at Mentor, where he held various Sales, Marketing and Management roles including Chief Operating Officer and Senior Vice President of Global Sales and Marketing. Prior to Mentor, Mr. Levine served as President and Chief Executive Officer of Immucor Corporation. Mr. Levine holds a Bachelor of Arts degree in Communications from the University of Arizona and has completed Executive Management Programs at Stanford University, Graduate School of Business and the University of Pennsylvania, Wharton School.

Barbara R. Paul, M.D.

Dr. Paul serves as an advisor and board member to healthcare companies. In addition to her role on the board of Natus Medical, she serves on the board of Quorum Health Corporation, an owner and operator of general acute care hospitals and outpatient service providers. She served as Senior Vice President & Chief Medical Officer at Community Health Systems (CHS) from July 2007 to January 2015. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. (now Golden Living, Inc.).  Dr. Paul's career is grounded by twelve years as a board-certified internist and full-time primary care physician. She also worked at the federal Medicare program (Centers for Medicare & Medicaid Services, CMS) for appointees of Presidents Clinton and Bush. She was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin - Madison and earned her medical degree from Stanford University School of Medicine.

Lisa Wipperman Heine

Ms. Heine joined the Board in June 2018 and is currently Chief Operating Officer at Mitralign, Inc., a venture backed innovator of transcatheter heart valve technologies. Prior to joining Mitralign, she was the Founder and Principal at deArca Strategic Solutions, LLC, a consulting firm focused on helping medtech companies assess, develop and execute strategies related to market opportunities and technology adoption. Lisa has also served in multiple leadership roles at Covidien, Inc., including Global Vice President of Medical Affairs for Vascular Therapies. During her tenure at Covidien, she helped drive the strategy in support of a $1.7B business and was also responsible for leading the strategy and operations of Clinical Affairs, Healthcare Economics, Policy and Reimbursement and Medical Education functions. Lisa also currently serves as a member of the Board of Directors of Surmodics Inc. She received her undergraduate degree from St. Olaf College and graduate degree from the University of Manitoba.

Barbara R. Paul, M.D.

Dr. Paul serves as an advisor and board member to healthcare companies. In addition to her role on the board of Natus Medical, she serves on the board of Quorum Health Corporation, an owner and operator of general acute care hospitals and outpatient service providers. She served as Senior Vice President & Chief Medical Officer at Community Health Systems (CHS) from July 2007 to January 2015. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. (now Golden Living, Inc.).  Dr. Paul's career is grounded by twelve years as a board-certified internist and full-time primary care physician. She also worked at the federal Medicare program (Centers for Medicare & Medicaid Services, CMS) for appointees of Presidents Clinton and Bush. She was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin - Madison and earned her medical degree from Stanford University School of Medicine.

Robert A. Gunst

Mr. Gunst joined the Board in June 2004 and was appointed Chairman of the Board in September 2004. Mr. Gunst has been a private investor since 1999. Mr. Gunst served as president and chief executive officer of The Good Guys, Inc., an electronics retailer, from 1990 to 1999, and as a member of its board of directors from 1986 to 1999.  Prior to joining The Good Guys, Mr. Gunst held senior management and director positions at Shaklee Corporation, La Petite Boulangerie, Inc. and PepsiCo Foods International, both subsidiaries of PepsiCo, Inc., Victoria Station Incorporated, and The First National Bank of Chicago.  He holds a Bachelor of Arts degree in Economics from Dartmouth College and a Masters Degree in Business Administration from the University of Chicago’s Graduate School of Business. Mr. Gunst brings to the Board knowledge and experience gained from decades of managing and directing public and private companies across several industries.

Lisa Wipperman Heine

Ms. Heine joined the Board in June 2018 and is currently Chief Operating Officer at Mitralign, Inc., a venture backed innovator of transcatheter heart valve technologies. Prior to joining Mitralign, she was the Founder and Principal at deArca Strategic Solutions, LLC, a consulting firm focused on helping medtech companies assess, develop and execute strategies related to market opportunities and technology adoption. Lisa has also served in multiple leadership roles at Covidien, Inc., including Global Vice President of Medical Affairs for Vascular Therapies. During her tenure at Covidien, she helped drive the strategy in support of a $1.7B business and was also responsible for leading the strategy and operations of Clinical Affairs, Healthcare Economics, Policy and Reimbursement and Medical Education functions. Lisa also currently serves as a member of the Board of Directors of Surmodics Inc. She received her undergraduate degree from St. Olaf College and graduate degree from the University of Manitoba.